Skip to main content

Lapse in Appropriations

Please note that a lapse in appropriations has caused GAO to shut down its operations. Therefore, GAO will not be able to publish reports or otherwise update this website until GAO resumes operations. In addition, the vast majority of GAO personnel are not permitted to work. Consequently, calls or emails to agency personnel may not be returned until GAO resumes operations. For details on how the bid protest process will be handled during the shutdown, please see the legal decisions page. For information related to the GAO Personnel Appeals Board (PAB), please see the PAB webpage.

Drug Prices: Effects of Opening Federal Supply Schedule for Pharmaceuticals Are Uncertain

HEHS-97-60 Published: Jun 11, 1997. Publicly Released: Jun 11, 1997.
Jump To:

Highlights

GAO reviewed the factors that can affect negotiations for schedule drug prices and the potential effects of opening the pharmaceutical schedule on schedule prices available to federal, state, and local government purchasers. Although GAO reviewed economic and other assumptions used in these assessments, GAO did not validate the supporting data, such as drug prices and expenditures.

Full Report

Full Report (26 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Public Inquiries

Contact Us

Topics

Health Care
Cooperative agreementsDrugsFederal supply systemsHealth care programsHospitalsLocal governmentsPharmaceutical industryPrice regulationState and local procurementState governmentsMedicaid